CVE-2021-38425

CRITICALCVSS 9.1/10EPSS 4.91%

Last modified

CVE-2021-38425 is a critical-severity vulnerability rated 9.1/10 on the CVSS scale. eProsima Fast DDS versions prior to 2.4.0 (#2269) are susceptible to exploitation when an attacker sends a specially crafted packet to flood a target device with unwanted traffic, which may result in a denial-of-service condition and information exposure.. EPSS estimates a 4.91% chance of exploitation in the next 30 days.

Description

eProsima Fast DDS versions prior to 2.4.0 (#2269) are susceptible to exploitation when an attacker sends a specially crafted packet to flood a target device with unwanted traffic, which may result in a denial-of-service condition and information exposure.

Metrics

CVSS 3.1
9.1/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:H

EPSS Probability
4.91%

91.0th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
EprosimaFast Dds< 2.4.0

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2021-38425?
eProsima Fast DDS versions prior to 2.4.0 (#2269) are susceptible to exploitation when an attacker sends a specially crafted packet to flood a target device with unwanted traffic, which may result in a denial-of-service condition and information exposure.
How severe is CVE-2021-38425?
CVE-2021-38425 has a CVSS score of 9.1/10 (CRITICAL severity). The EPSS model estimates a 4.91% probability of exploitation in the next 30 days.
How do I fix CVE-2021-38425?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2021-38425?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST